Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatm...
Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE
About this item
Full title
Author / Creator
Publisher
England: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
England: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
ObjectiveTo examine the long-term changes in circulating B cell subsets and IgG levels at 5+ years of continuous belimumab treatment and their correlations with efficacy and safety measures.MethodsThis was a post hoc analysis of a continuation study (BEL112233; NCT00724867) of eligible US patients who completed the 76-week BLISS-76 Study (BEL110751...
Alternative Titles
Full title
Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_22de3cc72bf2458aa9500f454d153a48
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_22de3cc72bf2458aa9500f454d153a48
Other Identifiers
ISSN
2053-8790
E-ISSN
2053-8790
DOI
10.1136/lupus-2021-000499
